S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
New CBOE “special perk” helps traders target income every weekend (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
New CBOE “special perk” helps traders target income every weekend (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
New CBOE “special perk” helps traders target income every weekend (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
New CBOE “special perk” helps traders target income every weekend (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
New CBOE “special perk” helps traders target income every weekend (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts

Cardinal Health Stock Price, News & Analysis (NYSE:CAH)

$105.87
-1.27 (-1.19%)
(As of 12/6/2023 ET)
Compare
Today's Range
$104.91
▼
$106.94
50-Day Range
$86.38
▼
$107.46
52-Week Range
$68.53
▼
$108.03
Volume
1.35 million shs
Average Volume
2.28 million shs
Market Capitalization
$26.09 billion
P/E Ratio
173.56
Dividend Yield
1.89%
Price Target
$96.83
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Cardinal Health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
8.5% Downside
$96.83 Price Target
Short Interest
Healthy
3.35% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.65
Upright™ Environmental Score
News Sentiment
0.77mentions of Cardinal Health in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$3.90 M Sold Last Quarter
Proj. Earnings Growth
11.47%
From $6.89 to $7.68 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

231st out of 957 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 5 stocks

See Top Rated MarketRank™ Stocks Here

CAH stock logo

About Cardinal Health Stock (NYSE:CAH)

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

CAH Stock Price History

CAH Stock News Headlines

November 28, 2023 | marketbeat.com
Teva Pharma is the way to play the re-rise of generic drugs (CAH)
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
December 4, 2023 | finance.yahoo.com
McKesson (MCK) Announces Availability of FDA-Cleared Drug
December 7, 2023 | DTI Trader (Ad)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
December 2, 2023 | americanbankingnews.com
Cardinal Health, Inc. (NYSE:CAH) CEO Deborah Weitzman Sells 36,642 Shares
December 1, 2023 | reuters.com
US FDA says BD is recalling infusion pumps due to compatibility issues
November 29, 2023 | finance.yahoo.com
Insider Sell: CEO Deborah Weitzman Offloads Shares of Cardinal Health Inc
November 27, 2023 | msn.com
Cardinal Health (CAH) Price Target Increased by 10.03% to 110.93
November 27, 2023 | finance.yahoo.com
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
December 7, 2023 | DTI Trader (Ad)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
November 24, 2023 | finance.yahoo.com
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
November 24, 2023 | finance.yahoo.com
Cardinal Health (CAH) Gets FDA Warning for Monoject Syringes
November 21, 2023 | finance.yahoo.com
Nevro's (NVRO) New Data Supports SCS Therapy for NSRBP Treatment
November 21, 2023 | msn.com
FDA warns on using Cardinal Health Monoject syringes with certain pumps
November 20, 2023 | stocknews.com
3 Medical Stocks Elevating Investors' Profit Potential
November 20, 2023 | finance.yahoo.com
UPDATE 2-FDA warns against using Cardinal's syringes
November 20, 2023 | msn.com
FDA warns against using Cardinal's syringes, pain-control pumps
November 17, 2023 | markets.businessinsider.com
JP Morgan Maintains Neutral Rating for Cardinal Health: Here's What You Need To Know
November 16, 2023 | finance.yahoo.com
Zacks.com featured highlights Cboe Global, Parker-Hannifin, Microsoft, FedEx and Cardinal Health
November 14, 2023 | msn.com
Cardinal Health issues product correction recall for syringes
November 10, 2023 | msn.com
Cardinal Health (CAH) Launches Surgical Gown for Safe Surgery
November 9, 2023 | finance.yahoo.com
Cardinal Health launches SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets
November 8, 2023 | theglobeandmail.com
3 Dividend Aristocrats Beating the Market in 2023
November 8, 2023 | finance.yahoo.com
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
November 7, 2023 | finance.yahoo.com
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
November 6, 2023 | bizjournals.com
Covid-19 vaccines help Cardinal beat quarterly expectations, raise FY24 guidance
November 3, 2023 | finance.yahoo.com
Q1 2024 Cardinal Health Inc Earnings Call
November 3, 2023 | msn.com
Major Healthcare Service Provider Cardinal Health Issues Upbeat Outlook, Shares Rise
See More Headlines
Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/15 Dividend
10/02/2023
Dividend Payable
10/15/2023
Last Earnings
11/03/2023
Today
12/06/2023
Ex-Dividend for 1/15 Dividend
12/29/2023
Dividend Payable
1/15/2024
Next Earnings (Estimated)
2/01/2024
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
Current Symbol
NYSE:CAH
CUSIP
14149Y10
CIK
721371
Web
www.cardinalhealth.com
Phone
(614) 757-5000
Fax
614-757-6000
Employees
48,000
Year Founded
1971

Price Target and Rating

Average Stock Price Target
$96.83
High Stock Price Target
$112.00
Low Stock Price Target
$85.00
Potential Upside/Downside
-8.5%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
9 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.61
Trailing P/E Ratio
173.56
Forward P/E Ratio
15.37
P/E Growth
1.02
Net Income
$261 million
Net Margins
0.07%
Pretax Margin
0.24%
Return on Equity
-60.27%
Return on Assets
3.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.99
Quick Ratio
0.50

Sales & Book Value

Annual Sales
$205.01 billion
Price / Sales
0.13
Cash Flow
$8.58 per share
Price / Cash Flow
12.34
Book Value
($11.20) per share
Price / Book
-9.45

Miscellaneous

Outstanding Shares
246,470,000
Free Float
246,098,000
Market Cap
$26.09 billion
Optionable
Optionable
Beta
0.80

Social Links

The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Cardinal Health was last updated on Tuesday, November 28, 2023 at 1:34 PM.

Pros

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

  • Recent developments in the healthcare industry, such as the crackdown on 'below radar' deals by FTC Chair Lina Khan, could create more competition in the market and potentially benefit Cardinal Health, Inc.
  • Cardinal Health, Inc. has a strong track record of industry diversification and innovation, which supports future growth prospects.
  • Investors may find the current stock price of Cardinal Health, Inc. attractive, providing a potential opportunity for investment.
  • Cardinal Health, Inc. operates in the healthcare sector, which is known for its stability and long-term growth potential.
  • Recent developments in Medicare price negotiations could impact pharmaceutical stocks positively, and Cardinal Health, Inc. may benefit from this trend.

Cons

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

  • There may be potential risks associated with the healthcare industry, such as regulatory changes and market uncertainties.
  • Investors should consider the potential impact of any future developments in Medicare price negotiations on Cardinal Health, Inc.'s financial performance.
  • Market conditions and competition within the healthcare sector could affect Cardinal Health, Inc.'s market share and profitability.
  • Investors should carefully evaluate the company's financial health and performance, including factors such as revenue growth, profitability, and debt levels.
  • It is important to consider the potential impact of any future regulatory actions or investigations on Cardinal Health, Inc.'s operations and reputation.














CAH Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardinal Health stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings or view top-rated stocks.

What is Cardinal Health's stock price target for 2024?

9 Wall Street research analysts have issued 12 month price objectives for Cardinal Health's shares. Their CAH share price targets range from $85.00 to $112.00. On average, they anticipate the company's stock price to reach $96.83 in the next year. This suggests that the stock has a possible downside of 8.5%.
View analysts price targets for CAH or view top-rated stocks among Wall Street analysts.

How have CAH shares performed in 2023?

Cardinal Health's stock was trading at $76.87 at the start of the year. Since then, CAH stock has increased by 37.7% and is now trading at $105.87.
View the best growth stocks for 2023 here.

Are investors shorting Cardinal Health?

Cardinal Health saw a increase in short interest in November. As of November 15th, there was short interest totaling 8,210,000 shares, an increase of 18.5% from the October 31st total of 6,930,000 shares. Based on an average daily trading volume, of 2,090,000 shares, the short-interest ratio is presently 3.9 days. Approximately 3.4% of the shares of the stock are sold short.
View Cardinal Health's Short Interest.

When is Cardinal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 1st 2024.
View our CAH earnings forecast.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) announced its quarterly earnings results on Friday, November, 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts' consensus estimates of $1.40 by $0.33. The business had revenue of $54.76 billion for the quarter, compared to the consensus estimate of $54.85 billion. Cardinal Health had a negative trailing twelve-month return on equity of 60.27% and a net margin of 0.07%. The company's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.20 earnings per share.
Read the conference call transcript.

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health declared a quarterly dividend on Tuesday, November 14th. Stockholders of record on Tuesday, January 2nd will be paid a dividend of $0.5006 per share on Monday, January 15th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.89%. The ex-dividend date is Friday, December 29th.
Read our dividend analysis for CAH.

Is Cardinal Health a good dividend stock?

Cardinal Health (NYSE:CAH) pays an annual dividend of $2.00 per share and currently has a dividend yield of 1.87%. The company has been increasing its dividend for 27 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 327.87%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CAH will have a dividend payout ratio of 26.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

What ETFs hold Cardinal Health's stock?

ETFs with the largest weight of Cardinal Health (NYSE:CAH) stock in their portfolio include USCF Dividend Income Fund (UDI), First Trust Nasdaq Pharmaceuticals ETF (FTXH), WBI BullBear Yield 3000 ETF (WBIG), BlackRock Large Cap Value ETF (BLCV), LeaderShares AlphaFactor Tactical Focused ETF (LSAT), SEI Enhanced U.S. Large Cap Value Factor ETF (SEIV), First Trust Dorsey Wright Momentum & Value ETF (DVLU) and Invesco Bloomberg MVP Multi-factor ETF (PWC).

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health updated its FY24 earnings guidance on Friday, November, 3rd. The company provided EPS guidance of $6.75-7.00 for the period, compared to the consensus EPS estimate of $6.68.

What is Mike Kaufmann's approval rating as Cardinal Health's CEO?

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by a number of institutional and retail investors. Top institutional investors include FMR LLC (2.42%), Morgan Stanley (1.79%), Ameriprise Financial Inc. (1.67%), Invesco Ltd. (1.41%), Northern Trust Corp (1.36%) and Acadian Asset Management LLC (1.03%). Insiders that own company stock include Deborah Weitzman, Jessica L Mayer, Mary C Scherer, Michelle Brennan, Ola M Snow and Stephen M Mason.
View institutional ownership trends.

How do I buy shares of Cardinal Health?

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Cardinal Health have any subsidiaries?
The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Aero-Med LLC, Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Blue Robin LLC, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 LLC, Cardinal Health 104 LP, Cardinal Health 105 LLC, Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 132 LLC, Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 LLC, Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International India Private Limited, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health K.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Corporation, Cornerstone Rheumatology L.P., Covidien Manufacturing Solutions S.A., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, GetOutcomes LLC, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies LLC, Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR U.S. LLC, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Mirixa Corporation, Mirixa Corporation, MosaicGPO LLC, Mscripts, NaviHealth, One Cloverleaf LLC, Outcomes Incorporated, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Patient Recovery Business of Medtronic, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R.P. Scherer Corporation, RGH Enterprises LLC, RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Traverse GPO LLC, Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, and mscripts LLC.
Read More
This page (NYSE:CAH) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -